Measles outbreak in an asylum-seekers' shelter in Germany: Comparison of the implemented with a hypothetical containment strategy

Epidemiology and Infection

Volumn 140, Issue 9, 2012, Pages 1589-1598

  Takla, A ^a,b   Barth, A ^c   Siedler, A ^a   Stocker P ^a,b   Wichmann, O ^a   Delere Y ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c District Health Authority   (Germany)

Author keywords

Germany; mass vaccination; measles; outbreak; refugees

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMPARATIVE STUDY; EPIDEMIC; EPIDEMIOLOGICAL DATA; FEMALE; GERMANY; HEALTH CARE COST; HUMAN; INFANT; INFECTION CONTROL; MALE; MEASLES; MEASLES VACCINATION; PRESCHOOL CHILD; REFUGEE; SCHOOL CHILD; SEROLOGY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HUMANS; INFANT, NEWBORN; MALE; MASS VACCINATION; MEASLES; MEASLES VACCINE; MODELS, BIOLOGICAL; REFUGEES; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84864452224     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268811002597     Document Type: Article

References (29)

1. Pink Book Chapter 12. Measles (http://www.cdc.gov/vaccines/pubs/pinkbook/ downloads/meas.pdf). Accessed 14 July 2011.
2. Heymann D (ed.). Control of Communicable Diseases Manual, 19th edn. Washington, DC: American Public Health Association, 2008, pp. 402-408.
3. Anderson RM, May RM. Immunisation and herd immunity. Lancet 1990; 335: 641-645. (Pubitemid 20092661)
4. Robert Koch Institute. Recommendations by the German Standing Committee on Vaccination (STIKO)/July 2010 In german. Epidemiologisches Bulletin 2010; 30: 279-298.
5. Applications for asylum 2010. (http://www.bamf.de/cln- 111/SharedDocs/Pressemitteilungen/DE/2011/110117-0001-press emitteilung-bmi. html). Accessed 10 February 2011.
6. Report on migration 2009. (http://www.bmi.bund.de/Shared Docs/Downloads/DE/Broschueren/2011/Migrationsbericht- 2009-de.pdf?-blob= publicationFile). Accessed 3 May 2011.
7. Asylum Seeker Benefits Law. ·4 Benefits during disease, pregnancy and childbirth (http://bundesrecht.juris.de/asylblg/-4.html). Accessed 26 July 2011.
8. Gold H. About a measles outbreak among migrants in Munich in German. Epidemiologisches Bulletin 2010; 50: 501-504.
9. Niedermeier A, Dreweck C. Varicella: on a cluster among Somali asylum seekers in two shelters in Munich in German. Epidemiologisches Bulletin 2010; 48: 480-482.
10. Davis RM, et al. A cost-effectiveness analysis of measles outbreak control strategies. American Journal of Epidemiology 1987; 126: 450-459. (Pubitemid 17123844)
11. Shiell A, et al. Cost-effectiveness of measles outbreak intervention strategies. Australian and New Zealand Journal of Public Health 1998; 22: 126-132. (Pubitemid 28245958)
12. White CC, Koplan JP, Orenstein WA. Benefits and costs of immunization for measles, mumps and rubella. American Journal of Public Health 1985; 75: 739-744. (Pubitemid 15010474)
13. Wichmann O, et al. Futher efforts needed to achieve measles elimination in Germany: results of an outbreak investigation. Bulletin of the World Health Organization 2009; 87: 108-115.
14. Dayan GH, et al. The cost of containing one case of measles: the economic impact on the public health infrastructure-Iowa,2004.Pediatrics2005;116:e1-e4.
15. Sugarman DE, et al. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated. Pediatrics 2010; 125: 747-755.
16. Kremer JR, et al. High genetic diversity of measles virus, World Health Organization European Union Region, 2005-2006. Emerging Infectious Diseases 2008; 14: 107-114.
17. World Health Organization. Measles vaccines: WHO position paper. Weekly Epidemiological Record 2009; 84: 349-360.
18. Sheppeard V, et al. The effectiveness of prophylaxis for measles contacts in NSW. NSW Public Health Bulletin 2009; 20: 81-85.
19. Barrabeig I, et al. Effectiveness of measles vaccination for control of exposed children. Pediatric Infectious Disease Journal 2011; 30: 78-80.
20. Rice P, et al. MMR immunisation after contact with measles virus. Lancet 2004; 363: 569-570. (Pubitemid 38229465)
21. McKeever V, et al. Postexposure prophylaxis, isolation, and quarantine to control an import-associated measles outbreak-Iowa, 2004. Morbidity and Mortality Weekly Report 2004; 53: 969-971.
22. Sakuta H, Sawada S, Kuroki Y. Severity of measles among patients with incidental postexposure vaccination. Japanese Journal of Infectious Diseases 2008; 61: 304-306.
23. Watson JC, et al. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report. Recommendations and Reports 1998; 47: 1-57.
24. Plotkin SA, Orenstein WA, Offit PA (eds). Vaccines, 5th edn. Philadelphia: Saunders, 2008, pp. 353-398.
25. Barnett ED, Christiansen D, Figueira M. Seroprevalence of measles, rubella, and varicella in refugees. Clinical Infectious Diseases 2002; 35: 403-408. (Pubitemid 34852570)
26. Greenaway C, et al. Susceptibility to measles, mumps, and rubella in newly arrived adult immigrants and refugees. Annals of Internal Medicine 2007; 146: 20-24. (Pubitemid 351650316)
27. Rote Liste 2010 (http://www.rote-liste.de). Accessed 12 February 2011.
28. CDC Vaccine Price List (http://www.cdc.gov/vaccines/programs/vfc/cdc-vac- price-list.htm). Accessed 20 June 2011.
29. Robert Koch Institute. Vaccination coverage at school entry in Germany 2009 in German. Epidemiologisches Bulletin 2011; 16: 125-129.